Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 7.1%

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 45,600 shares, the short-interest ratio is presently 1.6 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a "buy" rating and set a $9.00 price objective on shares of Alpha Tau Medical in a report on Friday, November 22nd.

Alpha Tau Medical Stock Up 0.3 %

NASDAQ:DRTS traded up $0.01 during trading hours on Friday, hitting $3.91. The stock had a trading volume of 92,315 shares, compared to its average volume of 51,170. The company has a 50 day simple moving average of $2.99 and a two-hundred day simple moving average of $2.50. Alpha Tau Medical has a one year low of $1.75 and a one year high of $4.08.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.